Virginia’s Employment Commission has transformed operations, cutting appeals processing from months to days, boosting first ...
REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal diseases. "2026 is set to be a transformative year ...
Genelux Corporation ('Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced a proposed underwritten public offering of its common stock. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback